Received Jul 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | GC3N4 | IM / UN |
Initially patient developed symptoms with a fever and head swelling after 4-30-25 with no fever or swelling initially after birth. By 5-4-25 he was diagnosed with Intraventricular hemorrhage of newborn Grade IV, Cerebral ventriculomegaly 5-4-25, Periventricular leukomalacia 5-12-25, seizures in newborn 5-18-25, post hemorrhagic hydrocephalus 5-23-25, patent foramen ovale 5-25-25, and feeding difficulties 6-5-25.
NA
NA
NA
NA
EEG 7-12-25, head ultrasound 7-10-25, swallow/speech study 6-4-25, head ultrasound 6-4-25, chest x-ray 5-30-25, head ultrasound 5-28-25, pediatric transthoracic echocardiogram 5-24-25, intubation 5-23-25, lumbar puncture 5-22-25, EEG 5-22-25, EEG 5-19-25, MRI 5-18-25, lumbar puncture 5-18-25, Intubation 5-18-25, head ultrasound 5-17-25, head ultrasound 5-12-25, MRI 5-6-25, EEG 5-5-25, head ultrasound 5-4-25, lumbar puncture 5-4-25.